Information Library
Hear From the Experts - Thought leadership
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Enhancing a Culture of Safety in the Life Sciences Sector
October 6, 2009
Axel Olsen, Executive Director of Global Pharmacovigilance and Risk Management, stresses that stakeholder collaboration is the key to improving drug safety. -
Comparative Effectiveness Research as a Drug Development Tool
September 1, 2009
A Q&A with John Doyle, Vice President and Practice Leader of Quintiles Consulting, sheds light on the complex issue of comparative effectiveness research, and its strategic importance in successful and efficient biopharmaceutical development. -
Changing the Face of Cancer Research
August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, at TMD, a Quintiles Central Laboratory, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. -
Charting a New Course by Catalyzing Transformation
June 9, 2009
Adrian McKemey, Quintiles Consulting Product Development and Commercialization Practice Leader, and Michael Arlotto, Senior Vice President Corporate Development Quintiles, discuss how organizations are transforming their clinical organizations to more effectively deliver safer drugs. -
Placing Patients First
May 26, 2009
Regaining and restoring the public's trust in the pharmaceutical industry is of the utmost importance. -
Anatomy of a Managed Partnership
May 26, 2009
Partnering affords pharma the opportunity to bolster development pipelines without taking on additional risk or adding to fixed costs. -
Evidence-Based Development and Smarter Sourcing
March 9, 2009
Jay Norman, president of Quintiles Consulting, discusses the changing landscape of drug development and suggests that better, evidence-based decisions, combined with smart sourcing strategies, will differentiate the future winners. -
Overcoming Global Challenges
March 2, 2009
Learn about strategies to overcome globalization challenges from John Doyle, Market Access Practice Leader, and Geoff Garabedian, Regulatory and Quality Systems Practice Leader in podcast brought to you by PharmaVoice. -
A New Gold Standard
May 1, 2008
May 2008 - John Doyle, DrPH, practice leader for market access at Quintiles Consulting, discusses the concept of a health economic balance sheet and the need for evidence-based pricing for biopharmaceutical valuation.
Page 1 of 1 (9 items)